6-89932532-G-A
Variant summary
Our verdict is Benign. Variant got -7 ACMG points: 1P and 8B. PP2BP4_StrongBS2
The NM_021813.4(BACH2):c.2402C>T(p.Pro801Leu) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.000293 in 1,614,076 control chromosomes in the GnomAD database, with no homozygous occurrence. In-silico tool predicts a benign outcome for this variant. 15/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★★).
Frequency
Consequence
NM_021813.4 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Benign. Variant got -7 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
BACH2 | NM_021813.4 | c.2402C>T | p.Pro801Leu | missense_variant | 9/9 | ENST00000257749.9 | NP_068585.1 | |
BACH2 | NM_001170794.2 | c.2402C>T | p.Pro801Leu | missense_variant | 7/7 | NP_001164265.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
BACH2 | ENST00000257749.9 | c.2402C>T | p.Pro801Leu | missense_variant | 9/9 | 1 | NM_021813.4 | ENSP00000257749 | P1 |
Frequencies
GnomAD3 genomes AF: 0.000191 AC: 29AN: 152068Hom.: 0 Cov.: 31
GnomAD3 exomes AF: 0.000207 AC: 52AN: 251354Hom.: 0 AF XY: 0.000206 AC XY: 28AN XY: 135862
GnomAD4 exome AF: 0.000304 AC: 444AN: 1461890Hom.: 0 Cov.: 30 AF XY: 0.000304 AC XY: 221AN XY: 727246
GnomAD4 genome AF: 0.000191 AC: 29AN: 152186Hom.: 0 Cov.: 31 AF XY: 0.000148 AC XY: 11AN XY: 74414
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Jan 03, 2024 | The c.2402C>T (p.P801L) alteration is located in exon 9 (coding exon 4) of the BACH2 gene. This alteration results from a C to T substitution at nucleotide position 2402, causing the proline (P) at amino acid position 801 to be replaced by a leucine (L). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
not provided Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Labcorp Genetics (formerly Invitae), Labcorp | Dec 20, 2023 | This sequence change replaces proline, which is neutral and non-polar, with leucine, which is neutral and non-polar, at codon 801 of the BACH2 protein (p.Pro801Leu). This variant is present in population databases (rs201359587, gnomAD 0.03%), and has an allele count higher than expected for a pathogenic variant. This variant has not been reported in the literature in individuals affected with BACH2-related conditions. ClinVar contains an entry for this variant (Variation ID: 1408084). Advanced modeling of protein sequence and biophysical properties (such as structural, functional, and spatial information, amino acid conservation, physicochemical variation, residue mobility, and thermodynamic stability) performed at Invitae indicates that this missense variant is not expected to disrupt BACH2 protein function with a negative predictive value of 80%. In summary, the available evidence is currently insufficient to determine the role of this variant in disease. Therefore, it has been classified as a Variant of Uncertain Significance. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at